Barely Significant
← all excerpts

Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis.

Blood Adv · 2024 · PMC10907401 · PMID 38330190

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

a nonsignificant trendP = .050actually significant
The OS and CIR were not significantly different among the graft sources or between patients with and without letermovir prophylaxis, but we noted a nonsignificant trend toward improved OS in patients with letermovir prophylaxis who underwent PBSC transplantation ( P = .050; supplemental Figure 1 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.